Skip to content

De ICU KvL-studie / The ICU QOL-study

De ICU KvL-studie / The ICU QOL-study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20091
Enrollment
8
Registered
2014-05-20
Start date
2014-05-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Chronische Obstructieve Pulmonaire ziekte ICU KvL-studie Exacerbatie van COPD Kwaliteit van leven COPD Chronic Obstructive Pulmonary Disease ICU QOL-study Exacerbation of COPD Quality of life

Interventions

This study uses a cross-sectional design involving an in-depth interview. A total of 8 patients will undergo an in-depth interview for approximately 60 minutes.

Sponsors

Medisch Spectrum Twente (MST); The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion: 1. Patients who have had a ICU admission in the period from September 2012 to January 2014; 2. Patients whose ICU admission indication was exacerbation of COPD; 3. Patients who are able to speak in understandable Dutch.

Exclusion criteria

Exclusion criteria: Exclusion: 1. Patients with severe psychiatric morbidity, noticeable in the personal file of the patients. The interview may be stressful for this group

Design outcomes

Primary

MeasureTime frame
Het primary outcome measure consists of answering the question: how do COPD patients experience intensive care unit admission because of exacerbation and what is the impact on their quality of life?

Secondary

MeasureTime frame
The secundary outcome measure consists of answering the questions: 1. What are the experiences of patients with ICU admission because of exacerbation of COPD? 2. What is the impact of this ICU admission on the quality of life in people with COPD? 3. How did patients experience the treatment before, during and after ICU admission? 4. How do patients experience the information about possible ICU admission and treatment?

Contacts

Public ContactMarloes Mijnster

Afdeling Onderzoeksbureau Longgeneeskunde Postbus 50000

marloes_mijnster@hotmail.com(053) 487 36 66

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)